Publisher Full Text
Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.Clin Vaccine Immunol. 2009 Jan; 16(1):132-3.CV
Abstract
Cross-reactivity in the Platelia Aspergillus enzyme immunoassay was evaluated using 120 sera from patients with paracoccidioidomycosis, histoplasmosis, and cryptococcosis. At a cutoff value of 0.5, positivity rates were 50%, 67%, and 50%, respectively. The implications for these findings are discussed.
Links
MeSH
Pub Type(s)
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
19020109
Citation
Xavier, Melissa O., et al. "Cross-reactivity of Paracoccidioides Brasiliensis, Histoplasma Capsulatum, and Cryptococcus Species in the Commercial Platelia Aspergillus Enzyme Immunoassay." Clinical and Vaccine Immunology : CVI, vol. 16, no. 1, 2009, pp. 132-3.
Xavier MO, Pasqualotto AC, Cardoso IC, et al. Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol. 2009;16(1):132-3.
Xavier, M. O., Pasqualotto, A. C., Cardoso, I. C., & Severo, L. C. (2009). Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay. Clinical and Vaccine Immunology : CVI, 16(1), 132-3. https://doi.org/10.1128/CVI.00310-08
Xavier MO, et al. Cross-reactivity of Paracoccidioides Brasiliensis, Histoplasma Capsulatum, and Cryptococcus Species in the Commercial Platelia Aspergillus Enzyme Immunoassay. Clin Vaccine Immunol. 2009;16(1):132-3. PubMed PMID: 19020109.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.
AU - Xavier,Melissa O,
AU - Pasqualotto,Alessandro C,
AU - Cardoso,Isabel Cristina E,
AU - Severo,Luiz Carlos,
Y1 - 2008/11/19/
PY - 2008/11/21/pubmed
PY - 2009/1/31/medline
PY - 2008/11/21/entrez
SP - 132
EP - 3
JF - Clinical and vaccine immunology : CVI
JO - Clin Vaccine Immunol
VL - 16
IS - 1
N2 - Cross-reactivity in the Platelia Aspergillus enzyme immunoassay was evaluated using 120 sera from patients with paracoccidioidomycosis, histoplasmosis, and cryptococcosis. At a cutoff value of 0.5, positivity rates were 50%, 67%, and 50%, respectively. The implications for these findings are discussed.
SN - 1556-679X
UR - https://www.unboundmedicine.com/medline/citation/19020109/Cross_reactivity_of_Paracoccidioides_brasiliensis_Histoplasma_capsulatum_and_Cryptococcus_species_in_the_commercial_Platelia_Aspergillus_enzyme_immunoassay_
L2 - https://journals.asm.org/doi/10.1128/CVI.00310-08?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed
DB - PRIME
DP - Unbound Medicine
ER -